Cardiac Resynchronization Therapy (CRT) stands at the forefront of advanced cardiac interventions, offering a targeted solution for individuals grappling with heart failure. This sophisticated therapy involves the implantation of a specialized device, often a pacemaker, with the aim of harmonizing the contractions of the heart's ventricles. By precisely orchestrating these contractions, CRT addresses the synchronization challenges that often accompany heart failure, ultimately boosting the heart's efficiency. Through the optimized timing of electrical impulses, CRT enhances the heart's pumping capability, resulting in improved blood flow and overall cardiovascular function. The transformative impact of CRT is evident in its ability to alleviate symptoms, enhance exercise tolerance, and elevate the overall quality of life for many patients. This therapeutic approach continues to redefine the landscape of cardiac care, offering hope and improved outcomes for individuals navigating the complexities of heart failure.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt